EP 2 443 126 B1 relates to a molecule, simalikalactone E (SkE), and its use as medicament.
Brief outline of the case
The opposition was rejected and the opponents appealed.
The board confirmed the revocation.
Background of the patent
It was acknowledged in the patent that the Quassia amara plant had been used in traditional medicine against fevers and malaria throughout the north-western Amazon and as far afield as Central America.